Capricor Therapeutics
CAPR
#7976
Rank
C$0.40 B
Marketcap
C$8.81
Share price
-4.36%
Change (1 day)
-58.77%
Change (1 year)

Capricor Therapeutics (CAPR) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.17 Billion

According to Capricor Therapeutics 's latest financial reports the company's total assets are C$0.17 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$0.24 B214.03%
2023-12-31C$77.9 M14.6%
2022-12-31C$67.97 M29.05%
2021-12-31C$52.67 M19.33%
2020-12-31C$44.14 M204.11%
2019-12-31C$14.51 M15.23%
2018-12-31C$12.59 M-38.43%
2017-12-31C$20.46 M-18.79%
2016-12-31C$25.19 M13.02%
2015-12-31C$22.29 M40.91%
2014-12-31C$15.81 M168.35%
2013-12-31C$5.89 M9.31%
2012-12-31C$5.39 M286.4%
2011-12-31C$1.39 M-61.91%
2010-12-31C$3.66 M-3.79%
2009-12-31C$3.8 M-51.33%
2008-12-31C$7.82 M-54.1%
2007-12-31C$17.04 M
2006-12-31N/A-100%
2005-12-31C$0 M-57.11%
2004-12-31C$0 M-45.51%
2003-12-31C$0 M3444.84%
2002-12-31C$0 M-89.8%
2001-12-31C$0 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Cytokinetics
CYTK
C$1.99 B 1,036.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$5.16 M-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$267.12 B 152,398.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$5.90 B 3,273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.89 B 412.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$8.55 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA